Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.

Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) have developed a revolutionary new method to improve compact gene-editing tools known as base ...

A new approach uses AI and a bacterial evolution platform to improve small gene-editing tools. The optimized variants ...

The trajectory of base editing has been remarkable, progressing from the laboratory to patient care, treating debilitating or ...

The powerful gene-editing technique CRISPR–Cas9 might offer a way to make safer, more effective cancer-fighting immune cells ...

A silent revolution is unfolding inside Indian laboratories. From the patent-free power of an indigenous CRISPR tool to ...

A new gene editor may soon open the door to gene therapies for a wider array of diseases. Ask scientists what gene editing tool is most needed to advance gene therapy, and they'd probably describe a ...

Rutgers Brain Health Institute supports students through federally funded training grants, scholar programs, and ...

A new form of CAR T kills leukemia, multiple myeloma, and sarcoma in mice, opening the door to a future off-the-shelf cancer treatment without chemotherapy.

Editas Medicine (NASDAQ:EDIT) executives outlined the company’s in vivo CRISPR gene-editing strategy and near-term clinical plans during a recent discussion featuring President and CEO Gilmore O’Neill ...

The researchers say that, to their knowledge, this is the first demonstration of programmable, site-specific integration of a large DNA payload into T cells in vivo.

Researchers identified TBC1D9B as the off switch for ARL8B, a key regulator of lysosome positioning. This mechanism controls how cells adapt to nutrient stress and maintain metabolic balance.